Longevity
Immune
Preclinical
Research chemical

PNC-27

Also known as PNC-27 · p53-HDM2 anticancer peptide

New

Reconstitution & dosing guide

5 mg vial — research phases, recon steps, and a live unit calculator.

Open guide

Available sizes & price

Catalog only

5mg x 10 vials

PNC-27 · Not in current stock

$45 / vial

Add

Prices per vial · Research use only · Not medical advice.

Chimeric peptide combining a p53 HDM-2-binding segment with a membrane-penetration motif; studied for selective cancer cell membrane disruption in preclinical oncology research.

How to picture it

A research peptide designed to recognize HDM-2 on certain cancer cell surfaces and disrupt their membranes. Picture a targeted hole-puncher aimed at marked tumor cells in preclinical models — experimental oncology tool concept: precise, high-stakes research only.

Research focus & benefits

  • Experimental oncology membrane-disruption research
  • HDM-2 surface-targeting studies
  • Preclinical selective cancer-cell models

Benefits describe research interest and pathway rationale — not guaranteed outcomes or medical advice. Research use only.

Overview

PNC-27 was designed to target HDM-2-expressing cancer cell membranes and induce necrosis-like pore formation. Preclinical papers report selective killing of various tumor lines with less effect on untransformed cells. It is an experimental oncology research peptide — not an anti-aging supplement.

Mechanism

Binds membrane-associated HDM-2 on cancer cells; transmembrane domain inserts and disrupts membrane integrity leading to cell death. Distinct from classic nuclear p53 reactivation drugs.

Research uses

  • In vitro cancer cell line cytotoxicity panels
  • Xenograft tumor models
  • HDM-2 membrane biology research

Research dosing notes

Oncology research protocols only. No approved human dosing for wellness.

Open full reconstitution & dosing guide →

Half-life / kinetics

Research-dependent

Common research routes

Subcutaneous injection
Intravenous

Reported considerations

  • Unknown systemic toxicity
  • Potential off-target membrane effects

Contraindications / cautions

  • Self-treatment of cancer is dangerous — oncology care only
  • Pregnancy

Legal / access note

Experimental anticancer research peptide. Not approved cancer therapy. Not for self-medication.